What goes up can come down. Investors who jumped on the Hims & Hers Health (NYSE: HIMS) bandwagon have experienced this pain ...

Advanced treatment options and hair-loss clinics have continued to emerge — and researchers are making progress on finding ...

Explore what to expect now that the Hims & Hers stock price now that it has crashed hard in the past few weeks.

We're one step closer to not just treating baldness but preventing it, with scientists making an important discovery that ...

Hair loss can be an unpleasant experience, especially for women. Stress, hormone fluctuation, and vitamin deficiencies are ...

Over 10,000 of these serums were purchased in the last month alone, which shows you just how much attention it's been getting ...

Researchers assessed data from 16 million patients from 2006 to 2020 taking semaglutide-based drugs; the active ingredient in Wegovy.

SHOPPING: Give yourself the gift of improved sense of self with the once-a-day treatment that contains ingredients to support ...

Hims & Hers Health is a top growth stock with strong cash flow, no debt, and an innovative AI-powered platform. Learn more on ...

The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents. The knockoff surge was led by Hims & Hers Health, the telehealth firm ...

A hair loss drug that first gained popularity in the 1990s is seeing a resurgence of interest. Minoxidil is best known as the ...

Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...